Skip to main content
. Author manuscript; available in PMC: 2020 Feb 5.
Published in final edited form as: Acta Oncol. 2017 Mar 24;56(8):1111–1119. doi: 10.1080/0284186X.2017.1304650

Table 3:

Cumulative incidence and proportions of late recurrences of colon and rectal cancer patients

Category Five-year cumulative incidence of colon cancer recurrence (95% CI) Ten-year cumulative incidence of colon cancer recurrence (95% CI) Proportion of late colon cancer recur-rences* Five-year cumulative incidence of rectal cancer recurrence (95% CI) Ten-year cumulative incidence of rectal cancer recurrence (95% CI) Proportion of late rectal cancer recur-rences*
Sex
 Females 23% (22%−24%) 27% (25%−28%) 6.0% 25% (23%−26%) 29% (27%−31%) 7.2%
 Males 26% (25%−27%) 30% (28%−31%) 5.5% 27% (26%−28%) 32% (30%−33%) 6.9%
Age group at surgery date
 <55 years 30% (28%−33%) 35% (32%−38%) 5.1% 34% (31%−37%) 40% (36%−44%) 6.3%
 55–64 years 28% (26%−30%) 34% (32%−36%) 8.0% 28% (26%−31%) 34% (31%−37%) 7.8%
 65–74 years 25% (24%−27%) 29% (28%−31%) 5.4% 26% (24%−28%) 30% (28%−33%) 6.8%
 75–84 years 21% (20%−22%) 24% (22%−26%) 5.2% 21% (19%−23%) 24% (22%−27%) 6.8%
 ≥85 years 16% (14%−18%) 16% (14%−19%) 1.8% 15% (11%−20%) 18% (13%−23%) 6.7%
AJCC tumor stage
 I 12% (10%−14%) 17% (14%−21%) 10% 13% (12%−15%) 16% (13%−18%) 5.8%
 II 18% (17%−19%) 22% (21%−24%) 8.4% 20% (19%−22%) 26% (24%−28%) 12%
 III 36% (35%−38%) 40% (38%−41%) 3.4% 41% (39%−43%) 45% (43%−47%) 4.2%
Lymph nodes with metastasis
 None 17% (16%−18%) 21% (20%−22%) 8.7% 18% (17%−19%) 23% (21%−24%) 10%
 1–3 30% (29%−32%) 34% (32%−36%) 4.4% 35% (33%−38%) 39% (37%−42%) 5.5%
 4–6 42% (39%−46%) 45% (42%−49%) 2.4% 47% (42%−52%) 52% (46%−57%) 4.0%
 7+ 50% (47%−54%) 54% (50%−58%) 2.3% 54% (49%−59%) 57% (51%−61%) 1.6%
Calendar period for date of cancer diagnosis
 2001–2004 25% (24%−26%) 29% (28%−30%) 11% 28% (26%−29%) 32% (30%−34%) 13%
 2005–2008 25% (24%−26%) 26% (24%−27%)
 2009–2011
Surgical technique
 Laparotomy 26% (25%−26%) 29% (28%−30%) 6.7% 27% (25%−28%) 31% (30%−32%) 8.1%
 Laparoscopy 20% (19%−22%) 22% (20%−24%) 1.5% 23% (20%−26%)
 Endoscopy 11% (3.9%−22%) 15% (5.7%−28%) 17% 31% (21%−43%)
Surgical urgency
 Elective 22% (21%−23%) 26% (25%−27%) 6.5% 26% (25%−27%) 30% (29%−32%) 7.1%
 Acute 39% (36%−41%) 41% (38%−43%) 3.0% 42% (31%−53%)
*

Number of late recurrences divided by total number of recurrences

No data reported; follow-up time is too short